Journal
VACCINE
Volume 26, Issue -, Pages A24-A27Publisher
ELSEVIER SCI LTD
DOI: 10.1016/j.vaccine.2007.11.059
Keywords
HPV; vaccines; serology; HPV typing
Categories
Ask authors/readers for more resources
The availability of two prophylactic HPV vaccines will. require thorough considerations about monitoring and surveillance of those vaccinated and the general population, respectively. Vaccinated poputations should be followed-up for long-term safety, sustained immune responses and vaccine efficacy. Effective monitoring will benefit from linkage of vaccination history and screening history, as well as precise measurement of HPV exposure, both DNA and serological. testing. Lack of record linkage in many settings is one of the main obstacles for an effective surveillance program, though other surveillance activities can make contributions to assessing HPV vaccine effectiveness, including information from organized screening programs and phase IV studies. (C) 2007 Elsevier Ltd. All rights reserved.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available